Search :
Sign in or Register  
Welcome Sign in or Don't have an account?Register

FANCE Antibodies

The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group E. [provided by RefSeq, Jul 2008]

Background

FANCE functions as an essential part of the Fanconi anemia DNA repair pathway which mainly exists in proliferating cells and tissues. The protein functions as a vital component for DNA cross-link repair and genomic stability maintenance which protects against chromosomal abnormalities and cancer formation. The protein complex of FANCE works to detect DNA damage for repair purposes which enables normal cell division and prevents excessive genetic mutations. Research on Fanconi anemia patients led to the initial discovery of FANCE which has since become a focus of extensive DNA repair mechanism studies. The discovery of FANCE has led to major breakthroughs in understanding cellular genetic maintenance processes and DNA damage responses which benefits cancer research and therapeutic development.

Structure Function ApplicationAdvantageOur Products

Structure of FANCE

FANCE is a relatively small protein with a molecular weight of approximately 55 kDa. This weight may slightly vary between species due to differences in glycosylation patterns or minor variations in amino acid sequence.

Species Human Mouse Rat
Molecular Weight (kDa) 60 60 60
Primary Structural Differences Composed of 536 amino acids, with a disordered region between residues 170 and 270 Contains 536 amino acids, with a structure highly similar to human FANCE Similar structure to human FANCE, with minor variations in non-critical regions

The protein FANCE (Fanconi Anemia Complementation Group E) is a key component of the Fanconi anemia (FA) DNA repair pathway and plays a crucial role in maintaining genomic stability. FANCE contains multiple conserved domains and displays a complex structure essential for its function. The protein structure of FANCE contains binding regions for other FA proteins which assemble into a central complex that enables DNA repair. The protein contains specific domains which enable it to move to areas where DNA damage occurs. The protein functions as a vital component in cells to stop chromosomal problems and defend against cancer development. FANCE works with other FA pathway proteins to control DNA interstrand cross-link repair which maintains cell cycle progression and prevents genomic instability.

Fig. 1:Structure of human FANCEFig. 1 Structure of human FANCE.1

Key structural properties of FANCE:

  • Conserved domains for pathway function
  • Interaction sites with FANCC and FANCG
  • Nuclear localization signals for DNA repair
  • Phosphorylation sites for regulation
  • Ubiquitination sites for DNA repair

Functions of FANCE

FANCE's primary function is DNA repair via the Fanconi anemia pathway. However, it is also involved in various cellular processes, including maintaining genomic stability and responding to DNA damage.

Function Description
DNA Repair Critical for repairing DNA interstrand cross-links
Genomic Stability Prevents chromosomal abnormalities and maintains genome integrity
Pathway Regulation Serves as a key regulator in the Fanconi anemia pathway
Protein Interactions Forms complexes with other FA proteins to mediate repair
Response to DNA Damage Localizes to sites of DNA damage to initiate repair processes

The function of FANCE in DNA repair is essential for maintaining genomic stability, in contrast to other proteins that may have broader roles, indicating its specialized role in preventing chromosomal abnormalities.

Applications of FANCE and FANCE Antibody in Literature

1. Lin, Bo, et al. "Integrated analysis of FANCE expression and its regulatory role in the immune microenvironment of oral squamous cell carcinoma." Oncology Letters 29.3 (2025): 160. https://doi.org/10.3892/ol.2025.14906

This article presents an integrated analysis of FANCE expression in oral squamous cell carcinoma, highlighting its regulatory role in the immune microenvironment. FANCE antibody was used as a key marker to investigate the protein's expression patterns and interactions with immune cells, demonstrating its significance in understanding tumor-immune dynamics and identifying potential therapeutic targets.

2. Nookala, Ravi K., Shobbir Hussain, and Luca Pellegrini. "Insights into Fanconi Anaemia from the structure of human FANCE." Nucleic Acids Research 35.5 (2007): 1638-1648. https://doi.org/10.1093/nar/gkm033

This article offers in-depth structural insights into human FANCE, shedding light on the molecular basis of Fanconi Anaemia. The study pinpoints key structural components of FANCE that underpin its role in DNA repair processes and highlights its significance in maintaining genome stability. These findings provide novel perspectives on the molecular mechanisms of Fanconi Anaemia and suggest potential therapeutic avenues for associated conditions.

3. Yin, Huan, Zhixian Zhou, and Chun Fu. "Fance deficiency impaired DNA damage repair of prospermatogonia and altered the repair dynamics of spermatocytes." Reproductive Biology and Endocrinology 22.1 (2024): 113. https://doi.org/10.1186/s12958-024-01284-w

This article investigates the impact of FANCE deficiency on DNA damage repair in prospermatogonia and spermatocytes. The study demonstrates that FANCE deficiency impairs DNA damage repair in prospermatogonia and alters the repair dynamics of spermatocytes, highlighting the critical role of FANCE in maintaining genomic integrity during spermatogenesis. The findings provide insights into the molecular mechanisms underlying reproductive cell development and the consequences of FANCE dysfunction.

4. Takahashi, Junichi, et al. "Fanconi anemia complementation group E, a DNA repair-related gene, is a potential marker of poor prognosis in hepatocellular carcinoma." Oncology 100.2 (2022): 101-113. https://doi.org/10.1159/000520582

The research examines how Fanconi Anemia Complementation Group E (FANCE) functions in hepatocellular carcinoma (HCC). The research demonstrates that FANCE functions as a prognostic indicator for poor outcomes in HCC patients because it belongs to the DNA repair gene family. The research shows that higher FANCE expression levels correlate with more severe tumor progression and shorter patient survival times which makes it important for both outcome prediction and treatment planning.

Company A: FANCE Antibodies for Research

Company A specializes in the production of high-quality FANCE antibodies for research and industrial applications. Our portfolio includes monoclonal and polyclonal antibodies tailored for ELISA, Flow Cytometry, Western blot, immunohistochemistry, and other diagnostic methodologies.

  • Custom FANCE Antibody Development: Tailor-made solutions to meet specific research requirements.
  • Bulk Production: Large-scale antibody manufacturing for industry partners.
  • Technical Support: Expert consultation for protocol optimization and troubleshooting.
  • Aliquoting Services: Conveniently sized aliquots for long-term storage and consistent experimental outcomes.

For further information regarding our FANCE antibodies, custom services, or technical assistance, please reach out to us via info@creative-biolabs.com.

Reference

  1. Nookala, Ravi K., Shobbir Hussain, and Luca Pellegrini. "Insights into Fanconi Anaemia from the structure of human FANCE." Nucleic Acids Research 35.5 (2007): 1638-1648. https://doi.org/10.1093/nar/gkm033

Anti-FANCE antibodies

+ Filters
Loading...
Submit A Review Fig.3 Signaling pathways in cancers. (Creative Biolabs Authorized) Fig.4 Protocols troubleshootings & guides. (Creative Biolabs Authorized) Submit A Review Fig.3 Signaling pathways in cancers. (Creative Biolabs Authorized) Fig.4 Protocols troubleshootings & guides. (Creative Biolabs Authorized)
Target: FANCE
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Human
Clone: G5
Application*: ELISA, IHC, WB
Target: FANCE
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Human
Clone: L5-P1E6
Application*: E, IH, WB
Target: FANCE
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CBXF-2841
Application*: DB, WB
Target: FANCE
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CBXF-1724
Application*: WB, IP, IF, E
Target: FANCE
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: CBXF-0291
Application*: WB
Target: FANCE
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: CBXF-2302
Application*: DB, WB
Target: FANCE
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Human
Clone: L5-P1E6/G5
Application*: WB, E, IH
More Infomation
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
IFImmunofluorescence
IHImmunohistochemistry
IPImmunoprecipitation
WBWestern Blot
EELISA
MMicroarray
CIChromatin Immunoprecipitation
FFlow Cytometry
FNFunction Assay
IDImmunodiffusion
RRadioimmunoassay
TCTissue Culture
GSGel Supershift
NNeutralization
BBlocking
AActivation
IInhibition
DDepletion
ESELISpot
DBDot Blot
MCMass Cytometry/CyTOF
CTCytotoxicity
SStimulation
AGAgonist
APApoptosis
IMImmunomicroscopy
BABioassay
CSCostimulation
EMElectron Microscopy
IEImmunoelectrophoresis
PAPeptide Array
ICImmunocytochemistry
PEPeptide ELISA
MDMeDIP
SHIn situ hybridization
IAEnzyme Immunoassay
SEsandwich ELISA
PLProximity Ligation Assay
ECELISA(Cap)
EDELISA(Det)
BIBioimaging
IOImmunoassay
LFLateral Flow Immunoassay
LALuminex Assay
CImmunohistochemistry-Frozen Sections
PImmunohistologyp-Paraffin Sections
ISIntracellular Staining for Flow Cytometry
MSElectrophoretic Mobility Shift Assay
RIRNA Binding Protein Immunoprecipitation (RIP)
Online Inquiry